Launch Diagnostics has announced a new distribution deal with Biocare Medical for its extensive range of IHC antibodies and reagents, plus associated automated solutions.
The products are now available from Launch to customers within England, Wales and Scotland.
Biocare Medical is an innovator in developing and supplying world-class automated immunohistochemistry instrumentation, and the full range of reagents for IHC laboratory testing. With over 300 antibodies in a variety of formats including concentrated, pre-optimised and pre-diluted, they can be applied to clinical and research needs. In addition, the Q Series and Ultraline antibody ranges are compatible with the Leica Bond system and Roche Benchmark system respectively.
Biocare’s new NeoPATH PRO (pictured) is an advanced staining platform which sets a new standard in automated staining for IHC. It offers intuitive automation and delivers high-capacity throughput, complete with optimised reagents and ready-to-use antibodies.
Contact Launch Diagnostics for more information or visit www.launchdiagnostics.com.